InflaRx NV (IFRX)
1.465
+0.14
(+10.98%)
USD |
NASDAQ |
Oct 19, 16:00
1.465
0.00 (0.00%)
After-Hours: 16:14
InflaRx Cash from Operations (Annual) : -39.86M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -39.86M |
| December 31, 2024 | -52.52M |
| December 31, 2023 | -40.88M |
| December 31, 2022 | -35.46M |
| December 31, 2021 | -47.20M |
| December 31, 2020 | -41.64M |
| Date | Value |
|---|---|
| December 31, 2019 | -48.36M |
| December 31, 2018 | -27.97M |
| December 31, 2017 | -13.71M |
| December 31, 2016 | -5.523M |
| December 31, 2015 | -3.668M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| MediGene AG | -- |
| BioNTech SE | 514.63M |
| Immatics NV | -199.34M |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Oncolytics Biotech, Inc. | -20.11M |